- Company Details
SBIR Phase I: Technology development and pre-clinical testing of a novel minimally invasive catheter-based blood clot-retrieval and clot-filtering deviceAmount: $150,000.00
This Small Business Innovation Research (SBIR) Phase I project aims to develop the industry's first catheter-based stroke treatment device that serves both as a blood clot-retrieval as well as a clot- ...SBIRPhase I2009National Science Foundation
Insera Therapeutics Inc.
Sacramento, CA, 95835-1637
|# of Employees:||2|
|Socially and Economically Disadvantaged:||Y|